# Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae

> **NCT02681263** · PHASE4 · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 25 (actual)

## Conditions studied

- Urinary Tract Infections

## Interventions

- **DRUG:** Temocillin

## Key facts

- **NCT ID:** NCT02681263
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2018-04
- **Final completion:** 2018-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2018-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02681263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02681263, "Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02681263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*